I.V. Additive Cap
by Baxa Corp., Sub. of Cook Group, Inc.
510(k) K802966
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK802966 | Date7 Jan 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KPE
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5025
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The I.V. Additive Cap is an intravenous container accessory designed for use in a general hospital setting. It functions as a closure or cap for intravenous containers.
This device is regulated under 21 CFR 880.5025 and received FDA 510(k) clearance in 1981. It is manufactured by Baxa Corp., a subsidiary of Cook Group, Inc.
Other devices from Baxa Corp., Sub. of Cook Group, Inc.
Questions
AI-generated answers, 27 Sep 2026
What is the primary purpose of the I.V. Additive Cap?
The I.V. Additive Cap is designed to function as a closure or cap for intravenous containers within a general hospital setting.
Who is the manufacturer of this device?
This device is manufactured by Baxa Corp., which is a subsidiary of the Cook Group, Inc.
What is the regulatory status of the I.V. Additive Cap?
The device is regulated under 21 CFR 880.5025 and received FDA 510(k) clearance in 1981 under the K-number K802966.